Earnings

Royalty Pharma published press releases by date and/or category

Royalty Pharma Announces Launch of Senior Notes Offering

NEW YORK (NY) - August 19, 2020 – Royalty Pharma plc announced today that it intends to offer, subject to market and other conditions, senior unsecured notes in multiple tranches (the “Notes”) in a private offering exempt from registration in accordance with Rule 144A and Regulation S under the

Royalty Pharma Reports Second Quarter 2020 Results

Strong double-digit growth in Net cash provided by operating activities (GAAP) and Adjusted Cash Receipts (1) (non-GAAP)   Company introduces 2020 guidance: Adjusted Cash Receipts expected to be $1,720 to $1,760 million   $1.7 billion of new acquisitions announced in 2020 NEW YORK , Aug.

Royalty Pharma Announces Pricing of Initial Public Offering

NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc today announced the pricing of the initial public offering of 77,681,670 shares of its Class A ordinary shares pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (“SEC”) at a price to

Royalty Pharma Raises $600 Million of Debt

New York, NY (US) – May 24, 2012  — Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, announced that it has successfully issued $600 million of incremental Term Loan B debt through RPI Finance Trust (“RPIFT”), bringing total

Stay up to date

Subscribe to Royalty Pharma news and alerts

Subscribe